Factors associated with postcesarean blood transfusion: a case control study

Abstract Objective Cesarean delivery (CD) is a known risk factor for postpartum hemorrhage. However, the characteristics associated with post-CD transfusion are not well-established. We aimed to assess blood transfusion rates and associated factors following CD. Methods A retrospective case-control study of women who underwent CD at a university hospital. The study group comprised all women who received blood transfusion following surgery. A control group of women who did not receive postoperative blood transfusion was assigned in a two-to-one ratio. Results During study period, the overall post-CD blood transfusion rate was 4.7%. The study group comprised 170 women, and the control group 340. Maternal age (aOR [95% CI]: 1.07 (1.03, 1.11), p = .001), parity (aOR [95% CI]: 1.26 (1.09, 1.47), p = .002), gestational hypertensive disorders (aOR [95% CI]: 4.07 (1.52, 10.91), p = .005), maternal comorbidities (aOR [95% CI]: 4.16 (1.88, 9.1), p < .001), lower predelivery hemoglobin level (aOR [95% CI]: 0.43 (0.34, 0.54), p < .001), and major placental abnormalities (aOR [95% CI]: 2.74 (1.04, 7.18), p = .04) were independently associated with blood transfusion requirement. Intrapartum characteristics associated with blood transfusion requirement included nonelective procedure (aOR [95% CI]: 3.21 (1.72, 5.99), p < .001), prolonged second stage of labor (aOR [95% CI]: 5.50 (2.57, 11.78), p < .001), longer duration of surgery (aOR [95% CI]: 1.03 (1.02, 1.04), p < .001), general anesthesia (aOR [95% CI]: 2.11 (1.14, 3.91), p = .02), and greater estimated operative blood loss (aOR [95% CI]: 5.72 (3.15, 10.36), p < .001). Conclusions Among women who underwent CD, we identified 11 factors associated with blood transfusion following surgery. Prospective studies are warranted to assess the implementations of prophylactic interventions to reduce transfusion rates among those deemed at high risk for CD-related bleeding.

[1]  A. Shushan,et al.  The role of supracervical hysterectomy in reducing blood products requirement in the management of placenta accreta: a case-control study , 2020, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[2]  E. Grandone,et al.  Low molecular weight heparin use during pregnancy and risk of postpartum hemorrhage: a systematic review and meta-analysis , 2019, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[3]  M. Rice,et al.  Predicting peripartum blood transfusion in women undergoing cesarean delivery: A risk prediction model , 2018, PloS one.

[4]  W. H. Pearse,et al.  American College of Obstetricians and Gynecologists , 2018, Definitions.

[5]  F. Sethna,et al.  Postpartum obstetric red cell transfusion practice: A retrospective study in a tertiary obstetric centre , 2018, The Australian & New Zealand journal of obstetrics & gynaecology.

[6]  K. Rabiu,et al.  Caesarean delivery-related blood transfusion: correlates in a tertiary hospital in Southwest Nigeria , 2018, BMC Pregnancy and Childbirth.

[7]  A. Caughey,et al.  ACOG practice bulletin: Clinical management guidelines for obstetrician-gynecologists , 2017 .

[8]  A. Rebarber,et al.  Risk factors for blood transfusion in patients undergoing high‐order Cesarean delivery , 2017, Transfusion.

[9]  Y. El‐Sayed,et al.  Risk Factors for Severe Postpartum Hemorrhage After Cesarean Delivery: Case-Control Studies , 2017, Anesthesia and analgesia.

[10]  Chunbo Li,et al.  Is prophylactic tranexamic acid administration effective and safe for postpartum hemorrhage prevention? , 2017, Medicine.

[11]  R. Abraham,et al.  Role of Prophylactic Tranexamic Acid in Reducing Blood Loss during Elective Caesarean Section: A Randomized Controlled Study. , 2016, Journal of clinical and diagnostic research : JCDR.

[12]  Hao Ying,et al.  Risk factors for transfusion in cesarean section deliveries at a tertiary hospital , 2016, Transfusion.

[13]  Y. Duan,et al.  Tranexamic acid and blood loss during and after cesarean section: a meta-analysis , 2015, Journal of Perinatology.

[14]  C. Taner,et al.  Predictors of severity in primary postpartum hemorrhage , 2015, Archives of Gynecology and Obstetrics.

[15]  G. Donzelli.  Medical humanities and narrative medicine in perinatal care , 2015, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

[16]  E. Main,et al.  Executive summary of the reVITALize initiative: standardizing obstetric data definitions. , 2014, Obstetrics and gynecology.

[17]  R. Rossaint,et al.  Is general anaesthesia for caesarean section associated with postpartum haemorrhage? Systematic review and meta‐analysis , 2013, Acta anaesthesiologica Scandinavica.

[18]  O. S. Cole,et al.  Maternal risk factors for peripartum transfusion. , 2012, Journal of women's health.

[19]  S. Haeri,et al.  Maternal mortality from hemorrhage. , 2012, Seminars in perinatology.

[20]  A. Mebazaa,et al.  Predictive factors of advanced interventional procedures in a multicentre severe postpartum haemorrhage study , 2011, Intensive Care Medicine.

[21]  P. Øian,et al.  Risks for peroperative excessive blood loss in cesarean delivery , 2010, Acta obstetricia et gynecologica Scandinavica.

[22]  S. Joung,et al.  Incidence and risk factors predicting blood transfusion in caesarean section , 2009, The Australian & New Zealand journal of obstetrics & gynaecology.

[23]  B. Stray-Pedersen,et al.  Prevalence and risk factors of severe obstetric haemorrhage , 2008, BJOG : an international journal of obstetrics and gynaecology.

[24]  B. Sibai,et al.  Blood Transfusion and Cesarean Delivery , 2006, Obstetrics and gynecology.

[25]  Jongun Lee,et al.  The Effects of Volatile Anesthetics on Spontaneous Contractility of Isolated Human Pregnant Uterine Muscle: A Comparison Among Sevoflurane, Desflurane, Isoflurane, and Halothane , 2006, Anesthesia and analgesia.

[26]  C. O'connell,et al.  Maternal and perinatal morbidity of caesarean delivery at full cervical dilatation compared with caesarean delivery in the first stage of labour , 2005, BJOG : an international journal of obstetrics and gynaecology.

[27]  K. Titlestad,et al.  Cesarean section: Is pretransfusion testing for red cell alloantibodies necessary? , 2005, Acta obstetricia et gynecologica Scandinavica.

[28]  D. Luton,et al.  Criteria for transfusion in severe postpartum hemorrhage: analysis of practice and risk factors. , 2004, European journal of obstetrics, gynecology, and reproductive biology.

[29]  S. Kozek-Langenecker.  The effects of drugs used in anaesthesia on platelet membrane receptors and on platelet function. , 2002, Current drug targets.

[30]  E Goodburn,et al.  Reducing maternal mortality in the developing world: sector-wide approaches may be the key , 2001, BMJ : British Medical Journal.

[31]  A. Caughey,et al.  Practice Bulletin No. 183: Postpartum Hemorrhage. , 2017, Obstetrics and gynecology.

[32]  P. Oian,et al.  Blood loss after cesarean delivery: a registry-based study in Norway, 1999-2008. , 2012, American journal of obstetrics and gynecology.

[33]  M. Yamakage,et al.  Sevoflurane inhibits contraction of uterine smooth muscle from pregnant rats similarly to halothane and isoflurane , 2002, Canadian journal of anaesthesia = Journal canadien d'anesthesie.